Sarepta Therapeutics, Inc. — Director's Dealing 2017

Nov 9, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Sarepta Therapeutics, Inc. (SRPT)
CIK: 0000873303
Period of Report: 2017-11-06

Reporting Person: Ruff Shamim (SVP, Regulatory Affairs & Qual)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-11-06	Common Stock	M	10000	$14.76	Acquired	37045	Direct
2017-11-06	Common Stock	S	10000	$55.00	Disposed	27045	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-11-06	Non-Qualified Stock Options (right to buy)	$14.76	M	10000	Disposed	2025-05-06	Common Stock (10000)	Direct

Footnotes

F1: This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person, on May 12, 2017, accordingly, the reporting person had no discretion with regards to the timing of the transaction.